Roth Capital Starts PhaseRx (PZRX) at Buy
Tweet
Share
E-mailGet Alerts PZRX Hot Sheet
Price: $0.28 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 42
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 42
Join SI Premium – FREE
Roth Capital initiated coverage on PhaseRx (NASDAQ: PZRX) with a Buy rating and a price target of $8.
For an analyst ratings summary and ratings history on PhaseRx click here. For more ratings news on PhaseRx click here.
Shares of PhaseRx closed at $5.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Starts Apotex Health Corp (APTX:CN) at Buy
- Jefferies Resumes York Space Systems (YSS) at Buy Following ALL.SPACE Acquisition
- Raymond James Starts First Carolina Financial Services (FCBM) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
